The following products:
[S—R
+
, S
+
)] N-[1-(mercaptomethyl)-2-phenylethyl]-alpha-[[phenylmethoxy) carbonyl] amino]-1H-indole-3-propanamide,
2′-cyano-alpha-[[[1-mercaptomethyl)-2-phenylethyl] amino] carbonyl] (1,2′-biphenyl)-4-propanoic acid,
(R)N-(1-mercaptomethyl)-2-phenylethyl)-11-phenoxy-undecanamide,
said products being in all possible racemic, enantiomeric and diastereoisomeric forms, as well as the addition salts with pharmaceutically acceptable mineral and organic bases of said products of formula (I) having an inhibitory activity on enothelin-converting enzymes.
以下产品:
S-R
+
, S
+
)]N-[1-(巯甲基)-2-苯基乙基]-alpha-[[
苯基甲氧基)羰基]
氨基]-1H-
吲哚-3-丙酰胺、
2′-
氰基-alpha-[[[1-巯甲基)-2-苯基乙基]
氨基]羰基](1,2′-
联苯)-4-
丙酸、
(R)N-(1-巯甲基)-2-苯乙基)-11-苯氧基十一酰胺、
所述产品为所有可能的外消旋体、对映体和非对映异构体形式,以及所述式(I)产品与药学上可接受的矿物碱和有机碱的加成盐,对enothelin-converting酶具有抑制活性。